Have $1,000 to Invest? This Dirt Cheap Pharma Stock Pays You 4.2% to Wait.
Key PointsBristol Myers Squibb has a moderately high forward dividend yield, but that's not the main appeal with this undervalued pharmaceutical stock.
Key PointsBristol Myers Squibb has a moderately high forward dividend yield, but that's not the main appeal with this undervalued pharmaceutical stock.